ANTI-ANGIOGENIC ACTIVITY OF THE EXTRACTED FERMENTATION BROTH OF AN ENTOMOPATHOGENIC FUNGUS, CORDYCEPS MILITARIS 3936

Authors

  • Hardeep S. Tuli Department of Biotechnology, Maharishi Markandeshwar University, Mullana-Ambala-133207
  • S. S. Sandhu Department of Biological Sciences, R. D. University, Jabalpur- 482001, (MP) India
  • Anil K. Sharma Department of Biotechnology, Maharishi Markandeshwar University, Mullana-Ambala-133207
  • Puneet Gandhi Department of Research in Medical Biotechnology, BMHRC, Bhopal (MP) India.

Keywords:

Cordyceps militaris, Solvent-solvent extraction, Cordycepin, Chorioallantoic membrane, Anti-angiogenic

Abstract

Objective: Cordyceps militaris is an entomopathogen and known to exhibit significant therapeutic potential. In the present study, we aimed to extract various fractions (aqueous; hexane; chloroform & butanol) including active ingredient cordycepin from fermented broth of Cordyceps militaris followed by their evaluation as anti-angiogenic agents.

Methods: The bioactive metabolite, cordycepin and various Cordyceps derived fractions were isolated from liquid culture of Cordyceps militaris using solvent-solvent extraction method followed by purification on silica gel column chromatography. Furthermore anti-angiogenic properties of extracted fermentation broth were also investigated using chorioallantoic membrane (CAM) assay.

Results: Butanolic fractions, demonstrated the highest anti-angiogenic activity followed by chloroform, hexane and aqueous fractions of extracted fermentation broth. Anti-angiogenic studies for extracted cordycepin showed that 40 µg/egg dosage of cordycepin was sufficient to inhibit the branching of blood vessels significantly (~50%) in a CAM assay.

Conclusion: It is concluded that butanolic extract/cordycepin from fermented broth of Cordyceps militaris potentially inhibits the angiogenesis and suggests that the inhibition of angiogenesis is one of the mechanisms by which Cordyceps militaris can mediate an anti-cancer effect.

Downloads

Download data is not yet available.

References

Folkman J. Angiogenesis in cancer vascular rheumatoid and other diseases. J Nat Med 1995;1:27-31.

Risau W. Mechanism of angiogenesis. J Nature1997;386:671-74.

Jain RK. Tumor angiogenesis and accessibility role of vascular endothelial growth factor. J Semin Oncol 2002;29:3-12.

Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. J Clin Cancer Res 2000;6:572-79.

Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.

Ferrara N, Gerber HP, Le Couter J. The biology of VEGF and its receptors. J Nat Med 2003;9:669-76.

Breier G, Risau W. The role of vascular endothelial growth factor in blood vessel formation. J Trends Cell Biol 1996;6:454-56.

Ahn YZ, Park SJ, Lee SG, Shin SC, Choi DH. Cordycepin:Selective Growth Inhibitor Derived from Liquid Culture of Cordyceps militaris against Clostridium spp. J Agric Food Chem 2000;48:2744-48.

Tuli HS, Sandhu SS, Sharma AK. Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin. J Biotech 2014;4(3):1-12.

Paterson RR. Cordyceps:a traditional Chinese medicine and another fungal therapeutic biofactory? J Phytochemistry 2008;69:1469-93.

Guo C, Zhu J, Zhang C, Zhang L. Determination of adenosine and 3′-deoxyadenosine in Cordyceps militaris (L.) Link. By HPLC. Chin. J Chinese Materia Medica 1998;23:236–43.

Xiao JH, Xiao DM, Xiong Q, Liang ZQ, Zhong JJ. Nutritional requirements for the hyperproduction of bioactive exopolysaccharides by submerged fermentation of the edible medicinal fungus Cordyceps taii. J Biochem Eng 2010;49:241–49.

Overgaard KH. The inhibition of 5-phosphoribosyl-1-pyrophosphate formation by Cordycepin triphosphate in extracts of Ehrlich ascites tumor cells. J Biochim Biophys Acta 1964;80:504–07.

Rottman F, Guarino AJ. The inhibition of phosphoribosyl-pyrophosphate amidotransferase activity by Cordycepin mono phosphate. J Biochim Biophys Acta 1964;89:465–72.

Holbein S, Wengi A, Decourty L, Freimoser FM, Jacquier A, DichtlrnaI B. Cordycepin interferes with 3’ end formation in yeast independently of its potential to terminate RNA chain elongation. RNA 2009;15:837–49.

Wong YY, Moon A, Duffin R, Barthet-Barateig A, Meijer HA, Clemens MJ, de Moor CH. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 2010;285:2610-21.

Tuli HS, Sandhu SS, Sharma AK, Kashyap D. Cordycepin:A bioactive metabolite with therapeutic potential. J Life Sci 2013;93:863-69.

Kim HG, Shrestha B, Lim SY, Yoon DH, Chang WC, Shin DJ, et al. Cordycepin inhibits lipopolysaccharide-induced inf lammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 2006;545:192–99.

Kredich NM, Guarino AJ. Improved method of isolation and determination of cordycepin. J Biochim Biophys Acta 1960;41:363-65.

Ribatti D, Vacca, A, Roncali, L, Dammacco, F. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 1996;40:1189-97.

Tuli HS, Sandhu SS, Kashyap D, Sharma AK. Optimization of extraction conditions and antimicrobial potential of a bioactive metabolite, cordycepin from Cordyceps militaris 3936. WJPPS 2014;3(4):1525-35.

Folkman, J. Tumor angiogenesis:therapeutic implications. N Eng J Med 1971;285:1182–86.

Morabito A, Sarmiento R, Bonginelli P, Giampietro G. Antiangiogenic strategies, compounds, and early clinical results in breast cancer. J Crit Rev Oncol Hematol 2004;49:91–107.

Park C, Hong SH, Lee JY, Kim GY, Choi BT, Lee YT, et al. Growth inhibition of U937 leukemia cells by aqueous extract of Cordyceps militaris through induction of apoptosis. J Oncol Rep 2005;13:1211–16.

Lee H, Kim YJ, Kim HW, Lee DH, Sung MK, Park T. Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells. J Biol Pharma Bull 2006;29:670–74.

Yoo HS, Shin JW, Cho JH, Son CG, Lee YW, Park SY et al. Effect of Cordyceps militaris extract on angiogenesis and tumor growth. J Acta Pharmacol Sin 2004;25:657-65.

Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, Wang WB. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. J BMC Cancer 2010;10:175-91.

Won SY, Park EH. Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris. J Ethnopharmacol 2005;96:555–61.

Deryugina EI, Quigley JP. CHAPTER TWO:Chick Embryo Chorioallantoic Membrane Models to Quantify Angiogenesis Induced by Inflammatory and Tumor Cells or Purified Effector Molecules. J Methods Enzymol 2008;444:21–41.

Published

01-07-2014

How to Cite

Tuli, H. S., S. S. Sandhu, A. K. Sharma, and P. Gandhi. “ANTI-ANGIOGENIC ACTIVITY OF THE EXTRACTED FERMENTATION BROTH OF AN ENTOMOPATHOGENIC FUNGUS, CORDYCEPS MILITARIS 3936”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 7, July 2014, pp. 581-3, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/2021.

Issue

Section

Original Article(s)